The global drug delivery market is projected to reach approximately USD 2.1 trillion by 2032, with steady growth anticipated throughout the forecast period. This expansion is fueled by the rising prevalence of chronic diseases, the increasing demand for personalized medicine, and continuous innovations in pharmaceutical delivery technologies. Advanced drug delivery solutions, such as targeted drug delivery, controlled release systems, and sustained release formulations, are at the forefront of this evolution, enabling improved therapeutic outcomes, reduced side effects, and enhanced patient compliance. In the pharmaceutical sector, oral drug delivery remains the most widely used route due to convenience and cost-effectiveness, with oral formulations and drug encapsulation techniques driving further innovation. Injectable drug delivery and parenteral delivery are gaining traction for biopharmaceuticals and precision medicine delivery, supported by the rise of biologics and biosimilars. Meanwhile, transdermal drug delivery, nanoparticle drug delivery, and smart drug delivery platforms are expanding their applications in oncology, diabetes, and central nervous system disorders, offering novel drug delivery industry strategies that optimize drug absorption and transport systems.
Drug Delivery overview
Published by MMR Statistics Research Team, Updated